TCT-729 Four-Year Clinical Outcomes in ‘Real-World’ Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent: Results from the PROMUS Element Plus US Post-Approval Study (PE-Plus PAS)
20170 citationsJournal Article
Field-Weighted Citation Impact: 0.00
TCT-729 Four-Year Clinical Outcomes in ‘Real-World’ Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent: Results from the PROMUS Element Plus US Post-Approval Study (PE-Plus PAS) | Researchclopedia